ChitogenX Inc.
CHNXFOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$627628
P/E Ratio—
52W High$0.0165
52W Low$0.0011
ChitogenX Inc. (CHNXF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CHNXF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2024Report Date: Dec 22, 2024EPS Actual
-$0.01
Est. -$0.01 · -39.5%
Revenue
—
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Dec 22, 2024
After Market Close
▼ Miss EPS
CHNXF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 30, 2026 | -$0.02 | — | — | — | — | — |
| ◌ Q2 FY2026 | Jun 8, 2026 | -$0.01 | — | — | — | — | — |
| ◌ Q2 FY2026 | Apr 1, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Mar 23, 2026 | -$0.02 | — | — | — | — | — |
| ◌ Q3 FY2025 | Jul 18, 2025 | — | — | — | — | — | — |
| ▼ Q4 FY2024 | Dec 22, 2024 | -$0.01 | -$0.01 | -39.5% | — | — | — |
| ▲ Q3 FY2024 | Sep 27, 2024 | -$0.01 | -$0.00 | +60.1% | — | — | — |
| ▲ Q1 FY2024 | Jan 31, 2024 | -$0.01 | -$0.00 | +72.5% | — | — | — |
Q2 FY2026
Jun 30, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 8, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 1, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 23, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 18, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 22, 2024Miss
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
-39.5%
Revenue
—
Q3 FY2024
Sep 27, 2024Beat
EPS Actual
-$0.00
EPS Est.
-$0.01
EPS Surpr.
+60.1%
Revenue
—
Q1 FY2024
Jan 31, 2024Beat
EPS Actual
-$0.00
EPS Est.
-$0.01
EPS Surpr.
+72.5%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2030 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2030 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2029 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2029 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q2 FY2029 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q1 FY2029 | $-0.02 | $-0.02 | $-0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2030 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2030 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2029 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2029 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2024 | Dec 22, 2024 | -39.5% | $0.02 | $0.02 | +0.00% |
| ▲ Q3 FY2024 | Sep 27, 2024 | +60.1% | $0.02 | $0.02 | +0.00% |
| ▲ Q1 FY2024 | Jan 31, 2024 | +72.5% | $0.07 | $0.06 | -3.08% |
| ▲ Q1 FY2024 | Jan 2, 2024 | +0.0% | $0.05 | $0.05 | +0.43% |
| ▲ Q3 FY2023 | Sep 29, 2023 | +50.0% | $0.09 | $0.09 | +0.00% |
| ▲ Q2 FY2023 | Jun 29, 2023 | +0.0% | $0.09 | $0.09 | +0.00% |
| — Q1 FY2023 | Jan 31, 2023 | — | $0.17 | $0.17 | +0.00% |
Q4 FY2024+0.00%
Report Date
Dec 22, 2024
EPS Beat/Miss
-39.5%
Price Before
$0.02
Price After
$0.02
Q3 FY2024+0.00%
Report Date
Sep 27, 2024
EPS Beat/Miss
+60.1%
Price Before
$0.02
Price After
$0.02
Q1 FY2024-3.08%
Report Date
Jan 31, 2024
EPS Beat/Miss
+72.5%
Price Before
$0.07
Price After
$0.06
Q1 FY2024+0.43%
Report Date
Jan 2, 2024
EPS Beat/Miss
+0.0%
Price Before
$0.05
Price After
$0.05
Q3 FY2023+0.00%
Report Date
Sep 29, 2023
EPS Beat/Miss
+50.0%
Price Before
$0.09
Price After
$0.09
Q2 FY2023+0.00%
Report Date
Jun 29, 2023
EPS Beat/Miss
+0.0%
Price Before
$0.09
Price After
$0.09
Q1 FY2023+0.00%
Report Date
Jan 31, 2023
EPS Beat/Miss
—
Price Before
$0.17
Price After
$0.17
Avg Beat Reaction-0.53%
Avg Miss Reaction+0.00%
Beat Rate5 / 7 quarters
Largest Move-3.08% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CHNXF ends December
ChitogenX Inc. (CHNXF) most recently reported earnings on December 22, 2024 for Q4 FY2024, posting EPS of $-0.01 — missing the analyst consensus of $-0.01 by -39.5%. The next CHNXF earnings date is expected around September 1, 2026.
Each quarter, investors track CHNXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CHNXF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CHNXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CHNXF earnings · 5 questionsChitogenX Inc.'s next earnings report is expected around September 1, 2026. CHNXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CHNXF historically reports after market close (AMC).
CHNXF earnings datewhen is CHNXF earningsCHNXF next earnings datewhen does CHNXF report earningsCHNXF earnings calendar
▸ Source: FMP · ChitogenX Inc. SEC filings · US GAAP · ChitogenX Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026